Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582972 · ClinicalTrials.gov registry record · Phase 4
Does Omeprazole Decrease Intestinal Calcium Absorption?
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT00582972 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 23 participants.
The verdict
NCT00582972, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the effect of omeprazole on intestinal calcium absorption in postmenopausal women.
Interventions
- DRUG Omeprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582972
The ClinicalTrials.gov registry entry for NCT00582972 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omeprazole is the first listed.
NCT00582972 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00582972 about?
NCT00582972 is a clinical study titled "Does Omeprazole Decrease Intestinal Calcium Absorption?". The purpose of this study is to measure the effect of omeprazole on intestinal calcium absorption in postmenopausal women.
What is the current status of trial NCT00582972?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2008-01. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00582972?
The interventions under investigation include: Omeprazole (DRUG).
Who is sponsoring clinical trial NCT00582972?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.